08:29 AM EDT, 07/29/2025 (MT Newswires) -- NeoGenomics ( NEO ) reported Q2 adjusted earnings Tuesday of $0.03 per diluted share, unchanged from a year earlier.

Analysts surveyed by FactSet expected $0.02 per share.

Revenue for the quarter ended June 30 was $181.3 million, up from $164.5 million a year earlier.

Analysts polled by FactSet expected $182.7 million.

The company said it now expects fiscal 2025 adjusted EPS of $0.08 to $0.12. That compares with its prior outlook of $0.16 to $0.20. Analysts surveyed by FactSet expect $0.15.

Revenue for the current year is now projected to be $720 million to $726 million, down from $747 million to $759 million previously, the company said. Analysts polled by FactSet expect $743.8 million.

Shares of the company were down more than 15% in recent Tuesday premarket activity.